Pinnacle Bancorp’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $121K | Hold |
958
| – | – | 0.03% | 317 |
|
|
2026
Q1 | $134K | Buy |
958
+129
| +16% | +$18.1K | 0.04% | 291 |
|
|
2025
Q4 | $102K | Hold |
829
| – | – | 0.03% | 328 |
|
|
2025
Q3 | $92K | Hold |
829
| – | – | 0.03% | 339 |
|
|
2025
Q2 | $91.9K | Sell |
829
-16
| -2% | -$1.7K | 0.03% | 330 |
|
|
2025
Q1 | $94.7K | Sell |
845
-692
| -45% | -$71.4K | 0.03% | 320 |
|
|
2024
Q4 | $142K | Hold |
1,537
| – | – | 0.05% | 262 |
|
|
2024
Q3 | $129K | Hold |
1,537
| – | – | 0.03% | 265 |
|
|
2024
Q2 | $105K | Hold |
1,537
| – | – | 0.03% | 271 |
|
|
2024
Q1 | $113K | Hold |
1,537
| – | – | 0.03% | 267 |
|
|
2023
Q4 | $125K | Sell |
1,537
-399
| -21% | -$31K | 0.04% | 242 |
|
|
2023
Q3 | $145K | Hold |
1,936
| – | – | 0.05% | 214 |
|
|
2023
Q2 | $149K | Buy |
1,936
+1,039
| +116% | +$82.9K | 0.05% | 217 |
|
|
2023
Q1 | $74.4K | Buy |
897
+154
| +21% | +$12.8K | 0.03% | 301 |
|
|
2022
Q4 | $64K | Sell |
743
-180
| -20% | -$14.3K | 0.02% | 305 |
|
|
2022
Q3 | $57K | Hold |
923
| – | – | 0.02% | 309 |
|
|
2022
Q2 | $57K | Sell |
923
-259
| -22% | -$16K | 0.02% | 316 |
|
|
2022
Q1 | $70K | Buy |
1,182
+259
| +28% | +$16.6K | 0.02% | 299 |
|
|
2021
Q4 | $67K | Hold |
923
| – | – | 0.02% | 310 |
|
|
2021
Q3 | $64K | Hold |
923
| – | – | 0.03% | 307 |
|
|
2021
Q2 | $64K | Hold |
923
| – | – | 0.03% | 308 |
|
|
2021
Q1 | $60K | Buy |
923
+493
| +115% | +$31.8K | 0.03% | 305 |
|
|
2020
Q4 | $25K | Sell |
430
-122
| -22% | -$7.36K | 0.02% | 434 |
|
|
2020
Q3 | $35K | Buy |
552
+89
| +19% | +$6.17K | 0.02% | 354 |
|
|
2020
Q2 | $36K | Hold |
463
| – | – | 0.03% | 330 |
|
|
2020
Q1 | $35K | Sell |
463
-300
| -39% | -$20.7K | 0.03% | 307 |
|
|
2019
Q4 | $50K | Sell |
763
-85
| -10% | -$5.54K | 0.03% | 304 |
|
|
2019
Q3 | $54K | Hold |
848
| – | – | 0.03% | 284 |
|
|
2019
Q2 | $57K | Buy |
848
+77
| +10% | +$5.07K | 0.03% | 280 |
|
|
2019
Q1 | $50K | Hold |
771
| – | – | 0.03% | 297 |
|
|
2018
Q4 | $48K | Buy |
+771
| New | +$53.9K | 0.03% | 287 |
|
|
2017
Q1 | $73K | Buy |
+1,074
| New | +$75.5K | 0.05% | 228 |
|
Other funds holding GILD
Pinnacle Bancorp's GILD Position: Q2 2026 in Review
Pinnacle Bancorp held its Gilead Sciences (GILD) position steady in Q2 2026 at 958 shares worth $121K. The position accounts for 0.03% of the portfolio, ranked #317.
Pinnacle Bancorp first reported a position in GILD in Q1 2017 and has held it in 32 quarters since. The position peaked at $149K in Q2 2023. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Pinnacle Bancorp held 958 shares of Gilead Sciences worth $121K as of Q2 2026.
- Pinnacle Bancorp left its Gilead Sciences share count unchanged in Q2 2026.
- Gilead Sciences made up 0.03% of Pinnacle Bancorp's portfolio in Q2 2026, its #317 holding.
- Pinnacle Bancorp first reported a position in Gilead Sciences in Q1 2017 and has held it in 32 quarters since.
- Pinnacle Bancorp's Gilead Sciences position peaked at $149K in Q2 2023.
- 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Pinnacle Bancorp's 13F filing for Q2 2026, filed 28 Jul 2026.